{"id":349290,"date":"2025-08-25T16:52:11","date_gmt":"2025-08-25T16:52:11","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-medpace-holdings\/"},"modified":"2025-08-25T16:52:11","modified_gmt":"2025-08-25T16:52:11","slug":"how-to-buy-medpace-holdings","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-medpace-holdings\/","title":{"rendered":"Medpace Holdings, Inc. (MEDP) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Medpace Holdings, Inc. (MEDP) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334036,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-349290","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"Medpace Holdings, Inc. (MEDP) Hisseleri Nas\u0131l Al\u0131n\u0131r - Medpace Holdings, Inc. (MEDP) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Medpace Holdings, Inc. (MEDP) Hisseleri Nas\u0131l Al\u0131n\u0131r - Medpace Holdings, Inc. (MEDP) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"Medpace Holdings, Inc. (MEDP) hisselerini nas\u0131l alaca\u011f\u0131n\u0131z\u0131 tam yat\u0131r\u0131m analizimizle \u00f6\u011frenin. G\u00fcncel hisse fiyat\u0131, riskler, b\u00fcy\u00fcme potansiyeli ve bu klinik ara\u015ft\u0131rma lideri i\u00e7in ad\u0131m ad\u0131m sat\u0131n alma s\u00fcrecini ke\u015ffedin.","description_source":{"label":"Description","type":"textarea","formatted_value":"Medpace Holdings, Inc. (MEDP) hisselerini nas\u0131l alaca\u011f\u0131n\u0131z\u0131 tam yat\u0131r\u0131m analizimizle \u00f6\u011frenin. G\u00fcncel hisse fiyat\u0131, riskler, b\u00fcy\u00fcme potansiyeli ve bu klinik ara\u015ft\u0131rma lideri i\u00e7in ad\u0131m ad\u0131m sat\u0131n alma s\u00fcrecini ke\u015ffedin."},"intro":"T\u0131bbi ara\u015ft\u0131rmay\u0131 devrim niteli\u011finde de\u011fi\u015ftiren bir \u015firkete yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Medpace Holdings (MEDP) sadece ba\u015fka bir biyoteknoloji hissesi de\u011fil\u2014say\u0131s\u0131z hayat kurtaran tedavinin arkas\u0131ndaki motor. Klinik deneyler giderek karma\u015f\u0131kla\u015ft\u0131k\u00e7a, bu s\u00f6zle\u015fmeli ara\u015ft\u0131rma organizasyonu sa\u011fl\u0131k inovasyonu ve k\u00e2rl\u0131l\u0131\u011f\u0131n\u0131n tam ortas\u0131nda yer al\u0131yor. MEDP'nin neden dikkatinizi hak etti\u011fini ve b\u00fcy\u00fcme hikayelerinin bir par\u00e7as\u0131 nas\u0131l olabilece\u011finizi ke\u015ffedelim.","intro_source":{"label":"Intro","type":"text","formatted_value":"T\u0131bbi ara\u015ft\u0131rmay\u0131 devrim niteli\u011finde de\u011fi\u015ftiren bir \u015firkete yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Medpace Holdings (MEDP) sadece ba\u015fka bir biyoteknoloji hissesi de\u011fil\u2014say\u0131s\u0131z hayat kurtaran tedavinin arkas\u0131ndaki motor. Klinik deneyler giderek karma\u015f\u0131kla\u015ft\u0131k\u00e7a, bu s\u00f6zle\u015fmeli ara\u015ft\u0131rma organizasyonu sa\u011fl\u0131k inovasyonu ve k\u00e2rl\u0131l\u0131\u011f\u0131n\u0131n tam ortas\u0131nda yer al\u0131yor. MEDP'nin neden dikkatinizi hak etti\u011fini ve b\u00fcy\u00fcme hikayelerinin bir par\u00e7as\u0131 nas\u0131l olabilece\u011finizi ke\u015ffedelim."},"body_html":"<h2>Medpace'in Mevcut Piyasa Konumunu Anlamak<\/h2> <p><strong>25 A\u011fustos 2025 itibar\u0131yla Medpace Holdings (MEDP) hisseleri hisse ba\u015f\u0131na 463,64 $ seviyesinde i\u015flem g\u00f6r\u00fcyor<\/strong>\u2014t\u00fcm zamanlar\u0131n en y\u00fcksek seviyelerine yak\u0131n etkileyici bir konum. Hisse senedi, patlay\u0131c\u0131 2. \u00e7eyrek kazan\u00e7 sonu\u00e7lar\u0131n\u0131n ard\u0131ndan 22 Temmuz 2025'te 477,73 $ zirvesine ula\u015farak inan\u0131lmaz bir yolculuk yapt\u0131.<\/p> <p>Takviminize not edin: <strong>20 Ekim 2025<\/strong> bir sonraki kritik tarihiniz. Medpace'in 3. \u00e7eyrek kazan\u00e7 raporunu yay\u0131nlayaca\u011f\u0131 g\u00fcn bu. Tarihsel olarak, bu a\u00e7\u0131klamalar \u00f6nemli \u00f6l\u00e7\u00fcde hareket yaratm\u0131\u015ft\u0131r.<\/p> <h3>Kazan\u00e7 Raporlar\u0131 MEDP Hissesini Nas\u0131l Hareket Ettirir<\/h3> <p>Son tarihleri inceledi\u011fimizde g\u00fc\u00e7l\u00fc kazan\u00e7 sonras\u0131 performans\u0131n net bir \u00f6r\u00fcnt\u00fcs\u00fc g\u00f6r\u00fcl\u00fcyor:<\/p> <table> <thead> <tr><th>Tarih<\/th><th>Olay<\/th><th>Haber \u00d6ncesi Fiyat<\/th><th>Haber Sonras\u0131 De\u011fi\u015fim<\/th><\/tr> <\/thead> <tbody> <tr><td>21 Temmuz 2025<\/td><td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>~400 $<\/td><td><strong>%57 art\u0131\u015f<\/strong><\/td><\/tr> <tr><td>Nisan 2025<\/td><td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>358 $<\/td><td><strong>%9,3 gelir art\u0131\u015f\u0131<\/strong><\/td><\/tr> <tr><td>Ocak 2025<\/td><td>\u00d6nceki Rehberlik<\/td><td>325 $<\/td><td><strong>\u0130stikrarl\u0131 y\u00fckseli\u015f<\/strong><\/td><\/tr> <tr><td>Ekim 2024<\/td><td>3. \u00c7eyrek 2024<\/td><td>298 $<\/td><td><strong>Beklentileri a\u015ft\u0131<\/strong><\/td><\/tr> <tr><td>Temmuz 2024<\/td><td>2. \u00c7eyrek 2024<\/td><td>275 $<\/td><td><strong>G\u00fc\u00e7l\u00fc sipari\u015f b\u00fcy\u00fcmesi<\/strong><\/td><\/tr> <tr><td>Nisan 2024<\/td><td>1. \u00c7eyrek 2024<\/td><td>250 $<\/td><td><strong>Piyasa toparlanmas\u0131<\/strong><\/td><\/tr> <\/tbody> <\/table> <p>\u00d6r\u00fcnt\u00fc a\u00e7\u0131k: Medpace, yat\u0131r\u0131mc\u0131lar\u0131 heyecanland\u0131ran sonu\u00e7lar sunmaya devam ediyor. En dramatik hareket, 2. \u00e7eyrek 2025 sonras\u0131 ger\u00e7ekle\u015fti; hisse senedi %57 patlad\u0131, gelir %14,2 artarak 603,3 milyon $ oldu ve hisse ba\u015f\u0131 kazan\u00e7 tahminleri 0,12 $ a\u015ft\u0131.<\/p> <h3>6 Ayl\u0131k Fiyat Yolculu\u011fu Analizi<\/h3> <p>\u015eubat-A\u011fustos 2025 aras\u0131nda MEDP hisseleri etkileyici bir performans sergiledi:<\/p> <ul> <li><strong>\u015eubat 2025<\/strong>: Yakla\u015f\u0131k 340 $ seviyesinde i\u015flem g\u00f6rerek 4. \u00e7eyrek 2024 sonu\u00e7lar\u0131n\u0131n ard\u0131ndan momentum kazand\u0131<\/li> <li><strong>Mart 2025<\/strong>: Pozitif sekt\u00f6r havas\u0131 ve biyoteknoloji finansman iyile\u015fmeleriyle 380 $ seviyesine ula\u015ft\u0131<\/li> <li><strong>May\u0131s 2025<\/strong>: %9,3 gelir art\u0131\u015f\u0131 g\u00f6steren g\u00fc\u00e7l\u00fc 1. \u00e7eyrek kazan\u00e7lar\u0131n\u0131n ard\u0131ndan 400 $ s\u0131n\u0131r\u0131n\u0131 a\u015ft\u0131<\/li> <li><strong>Temmuz 2025<\/strong>: 2. \u00e7eyrek sonu\u00e7lar\u0131 beklentileri a\u015f\u0131nca 477 $ seviyesine f\u0131rlad\u0131<\/li> <li><strong>A\u011fustos 2025<\/strong>: Yakla\u015f\u0131k 463 $ civar\u0131nda konsolide olarak sa\u011fl\u0131kl\u0131 destek seviyeleri g\u00f6steriyor<\/li> <\/ul> <p>Bu, yakla\u015f\u0131k olarak <strong>%36 b\u00fcy\u00fcme<\/strong> anlam\u0131na geliyor ve biyoteknoloji sekt\u00f6r\u00fc ile genel piyasa endekslerinin \u00e7ok \u00fczerinde bir performans sergiliyor.<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2> <p>Mevcut analist projeksiyonlar\u0131 ve \u015firket performans trendlerine dayanarak:<\/p> <ul> <li><strong>2025 Y\u0131l Sonu<\/strong>: 480-520 $ aral\u0131\u011f\u0131 (g\u00fc\u00e7l\u00fc tatil \u00e7eyre\u011fi performans\u0131 bekleniyor)<\/li> <li><strong>2026 Tahmini<\/strong>: 550-600 $ (piyasa geni\u015flemesi ve devam eden sipari\u015f d\u00f6n\u00fc\u015f\u00fcm\u00fc)<\/li> <li><strong>2028 Projeksiyonu<\/strong>: 700-800 $ (terap\u00f6tik alan hakimiyeti ve k\u00fcresel geni\u015fleme)<\/li> <li><strong>2030 Vizyonu<\/strong>: 900-1.100 $ (sekt\u00f6r liderli\u011fi ve potansiyel sat\u0131n almalar)<\/li> <\/ul> <p><strong>Karar<\/strong>: Uzun vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in G\u00dc\u00c7L\u00dc ALIM. \u015eirketin entegre CRO modeli, sa\u011flam m\u00fc\u015fteri ili\u015fkileri ve y\u00fcksek b\u00fcy\u00fcme potansiyeline sahip terap\u00f6tik alanlara maruziyeti, devam eden ba\u015far\u0131 i\u00e7in m\u00fckemmel bir konumda olmas\u0131n\u0131 sa\u011fl\u0131yor.<\/p> <h2>MEDP Yat\u0131r\u0131mc\u0131lar\u0131 i\u00e7in Risk Analizi<\/h2> <h3>Dikkate Al\u0131nmas\u0131 Gereken Potansiyel Riskler<\/h3> <ul> <li><strong>Biyoteknoloji Finansman Dalgalanmas\u0131<\/strong>: Medpace'in i\u015fi, biyoteknoloji \u015firketlerinin klinik deneyler i\u00e7in finansman sa\u011flamas\u0131na do\u011frudan ba\u011fl\u0131d\u0131r. Finansman s\u0131k\u0131la\u015ft\u0131\u011f\u0131nda (<a href=\"https:\/\/www.ainvest.com\/news\/medpace-50-stock-surge-unpacking-catalyst-clinical-outsourcing-giant-surge-2507\/\">2022'de g\u00f6r\u00fcld\u00fc\u011f\u00fc gibi<\/a>), iptal oranlar\u0131 dramatik \u015fekilde artabilir.<\/li> <li><strong>Y\u00fcksek De\u011ferleme Endi\u015feleri<\/strong>: 31,19 ileriye d\u00f6n\u00fck F\/K oran\u0131yla, baz\u0131 analistler hissenin k\u0131sa vadede tam de\u011ferine ula\u015fm\u0131\u015f olabilece\u011fini d\u00fc\u015f\u00fcn\u00fcyor. Ortalama analist fiyat hedefi 406 $ seviyesinde olup mevcut seviyelerden k\u0131sa vadeli d\u00fc\u015f\u00fc\u015f potansiyeli g\u00f6steriyor.<\/li> <li><strong>Rekabet Bask\u0131lar\u0131<\/strong>: CRO sekt\u00f6r\u00fc olduk\u00e7a rekabet\u00e7i olmaya devam ediyor, b\u00fcy\u00fck oyuncular s\u00fcrekli yenilik yap\u0131yor. Medpace'in %16,2 FAV\u00d6K marj\u0131, sekt\u00f6r ortalamas\u0131 olan %18-20'nin biraz gerisinde.<\/li> <li><strong>Reg\u00fclasyon Ba\u011f\u0131ml\u0131l\u0131\u011f\u0131<\/strong>: Medpace m\u00fc\u015fterilerine FDA\/EMA onay s\u00fcre\u00e7lerinde yard\u0131mc\u0131 olurken, herhangi b\u00fcy\u00fck bir d\u00fczenleyici de\u011fi\u015fiklik deney s\u00fcrelerini ve maliyetleri etkileyebilir.<\/li> <\/ul> <h3>2025 \u0130\u00e7in Olumlu \u0130\u015faretler<\/h3> <ul> <li><strong>Patlay\u0131c\u0131 B\u00fcy\u00fcme Momentum<\/strong>: 2. \u00e7eyrek 2025 sonu\u00e7lar\u0131 %14,2 gelir art\u0131\u015f\u0131 ve yeni i\u015f \u00f6d\u00fcllerinde %12,6 art\u0131\u015f g\u00f6sterdi ($620,5 milyon) (<a href=\"https:\/\/www.ainvest.com\/news\/medpace-holdings-45-stock-surge-deep-dive-q2-2025-earnings-future-clinical-outsourcing-2507\/\">AInvest<\/a>).<\/li> <li><strong>Devasa Sipari\u015f G\u00fcvencesi<\/strong>: 2,85 milyar $ sipari\u015f birikimi ve \u00f6n\u00fcm\u00fczdeki 12 ayda 1,75 milyar $ d\u00f6n\u00fc\u015f\u00fcm potansiyeli ile gelir g\u00f6r\u00fcn\u00fcrl\u00fc\u011f\u00fc son derece g\u00fc\u00e7l\u00fc.<\/li> <li><strong>Sekt\u00f6r R\u00fczgarlar\u0131<\/strong>: Klinik ara\u015ft\u0131rmalarda merkezi olmayan deneylere ve yapay zeka entegrasyonuna do\u011fru kay\u0131\u015f, Medpace'in g\u00fc\u00e7l\u00fc y\u00f6nleri ve hizmet teklifleriyle do\u011frudan \u00f6rt\u00fc\u015f\u00fcyor.<\/li> <li><strong>M\u00fc\u015fteri Tutma M\u00fckemmelli\u011fi<\/strong>: %95'in \u00fczerinde m\u00fc\u015fteri tutma oranlar\u0131, tam hizmet modelinin yap\u0131\u015fkanl\u0131\u011f\u0131n\u0131 ve hizmet kalitesini g\u00f6steriyor.<\/li> <\/ul> <h2>\u00d6nemli Haberlerin Etki Analizi<\/h2> <p>Medpace'in 2025 y\u0131l\u0131, tek b\u00fcy\u00fck bir hikaye ile \u015fekillendi: <strong>2. \u00c7eyrek Kazan\u00e7 Patlamas\u0131<\/strong>.<\/p> <p>21 Temmuz 2025'te \u015firket, piyasada \u015fok etkisi yaratan sonu\u00e7lar\u0131 a\u00e7\u0131klad\u0131:<\/p> <ul> <li>Gelir: 603,3 milyon $ (%14,2 Y\u0131ll\u0131k Art\u0131\u015f)<\/li> <li>Hisse Ba\u015f\u0131na Kazan\u00e7 (EPS): 3,10 $ (tahminleri 0,12 $ a\u015ft\u0131)<\/li> <li>Yeni i\u015f \u00f6d\u00fclleri: 620,5 milyon $ (%12,6 art\u0131\u015f)<\/li> <li>Sipari\u015f birikimi: 2,85 milyar $<\/li> <\/ul> <p>Hisse senedi, kazan\u00e7 s\u00fcrprizlerinin bu hisseyi ne kadar dramatik hareket ettirebilece\u011fini g\u00f6steren tarihi %57 art\u0131\u015fla yan\u0131t verdi. Bu izole bir olay de\u011fildi\u2014Medpace, analist takibine g\u00f6re EPS tahminlerini %100 oran\u0131nda a\u015fm\u0131\u015ft\u0131r.<\/p> <p>\u015eirket ayr\u0131ca 2025 tam y\u0131l rehberli\u011fini 2,42-2,52 milyar $ gelir ve 405-428 milyon $ GAAP net gelir olarak y\u00fckseltti, y\u00f6netimin devam eden uygulamaya olan g\u00fcvenini g\u00f6sterdi.<\/p> <h2>Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2> <p>T\u00fcm veri noktalar\u0131n\u0131 analiz ettikten sonra, i\u015fte uygulanabilir tavsiyem:<\/p> <ol> <li><strong>Ortalama Maliyetle Al\u0131m Yap\u0131n<\/strong>: Hissenin volatilitesi g\u00f6z \u00f6n\u00fcne al\u0131nd\u0131\u011f\u0131nda, pozisyonunuzu bir kerede tamamen almak yerine kademeli olarak olu\u015fturmay\u0131 d\u00fc\u015f\u00fcn\u00fcn<\/li> <li><strong>Kazan\u00e7 Uyar\u0131lar\u0131 Ayarlay\u0131n<\/strong>: Takviminize 20 Ekim'i i\u015faretleyin ve kazan\u00e7 sonras\u0131 f\u0131rsatlar i\u00e7in fiyat uyar\u0131lar\u0131 kurmay\u0131 d\u00fc\u015f\u00fcn\u00fcn<\/li> <li><strong>Uzun Vadeli D\u00fc\u015f\u00fcn\u00fcn<\/strong>: MEDP'nin i\u015f modeli, biyoteknoloji finansman d\u00f6ng\u00fclerini atlatabilecek sab\u0131rl\u0131 yat\u0131r\u0131mc\u0131lar\u0131 destekler<\/li> <li><strong>Esprili Ger\u00e7eklik Kontrol\u00fc<\/strong>: \"MEDP ticareti yapmak, klinik deney sonu\u00e7lar\u0131n\u0131 izlemek gibidir\u2014bazen \u00e7\u0131\u011f\u0131r a\u00e7an tedavi stat\u00fcs\u00fc al\u0131rs\u0131n\u0131z, bazen plasebo etkisi. Anahtar, istatistiksel anlaml\u0131l\u0131\u011f\u0131 sa\u011flamak i\u00e7in yeterli deneme sitesi (\u00e7e\u015fitlendirme) sahibi olmakt\u0131r!\"<\/li> <\/ol> <h2>Ad\u0131m Ad\u0131m: Medpace Holdings, Inc. (MEDP) Hisseleri Nas\u0131l Al\u0131n\u0131r<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Platformunuzu Se\u00e7in<\/td><td>NASDAQ eri\u015fimi ve rekabet\u00e7i komisyon oranlar\u0131 sunan bir arac\u0131 kurum se\u00e7in<\/td><\/tr> <tr><td>2<\/td><td>Hesab\u0131n\u0131z\u0131 Fonlay\u0131n<\/td><td>Fon transferi yap\u0131n\u2014bir\u00e7ok platform sadece 100 $ ile ba\u015flaman\u0131za izin verir<\/td><\/tr> <tr><td>3<\/td><td>G\u00fcncel Fiyat\u0131 Ara\u015ft\u0131r\u0131n<\/td><td>MEDP'nin 25 A\u011fustos 2025 itibar\u0131yla yakla\u015f\u0131k 463,64 $ olan g\u00fcncel fiyat\u0131n\u0131 kontrol edin<\/td><\/tr> <tr><td>4<\/td><td>Limit Emirleri Kullan\u0131n<\/td><td>Volatil d\u00f6nemlerde planlad\u0131\u011f\u0131n\u0131zdan daha fazla \u00f6deme yapmamak i\u00e7in maksimum al\u0131\u015f fiyat\u0131n\u0131z\u0131 belirleyin<\/td><\/tr> <tr><td>5<\/td><td>Pozisyonu \u0130zleyin<\/td><td>Yat\u0131r\u0131m\u0131n\u0131z\u0131 takip edin ve kazan\u00e7 tarihleri ile fiyat hedefleri i\u00e7in uyar\u0131lar kurmay\u0131 d\u00fc\u015f\u00fcn\u00fcn<\/td><\/tr> <\/tbody> <\/table> <h2>MEDP Yat\u0131r\u0131mc\u0131lar\u0131 \u0130\u00e7in Pocket Option Neden Mant\u0131kl\u0131?<\/h2> <p>MEDP gibi hisselerde pozisyon olu\u015fturmak isteyenler i\u00e7in Pocket Option, modern yat\u0131r\u0131m ihtiya\u00e7lar\u0131yla m\u00fckemmel uyum sa\u011flayan birka\u00e7 avantaj sunar:<\/p> <ul> <li><strong>Minimum Para Yat\u0131rma Esnekli\u011fi<\/strong>: Sadece 5 $ ile ba\u015flayarak stratejileri test edebilir veya MEDP pozisyonunuzu \u00f6nemli sermaye taahh\u00fcd\u00fc olmadan olu\u015fturmaya ba\u015flayabilirsiniz<\/li> <li><strong>H\u0131zl\u0131 Hesap Do\u011frulama<\/strong>: Tek bir belge kullanarak 1 dakikal\u0131k KYC s\u00fcreci sayesinde, kay\u0131t olmadan ticarete dakikalar i\u00e7inde ba\u015flayabilirsiniz<\/li> <li><strong>\u00c7e\u015fitli Para \u00c7ekme Se\u00e7enekleri<\/strong>: 100'den fazla para \u00e7ekme y\u00f6ntemi, konumunuz veya tercihiniz ne olursa olsun k\u00e2rlar\u0131n\u0131za kolay eri\u015fim sa\u011flar<\/li> <\/ul> <p>Bu \u00f6zellikler, MEDP gibi volatil hisselerde pozisyonlar\u0131n\u0131 kademeli olarak olu\u015fturmak isteyen yat\u0131r\u0131mc\u0131lar i\u00e7in Pocket Option'u \u00f6zellikle cazip k\u0131lar ve yat\u0131r\u0131m yakla\u015f\u0131m\u0131 \u00fczerinde esneklik ve kontrol sa\u011flar.<\/p> <h2>Medpace Holdings: Klinik Ara\u015ft\u0131rma G\u00fcc\u00fc<\/h2> <p>Medpace, biyoteknoloji, ila\u00e7 ve medikal cihaz \u015firketleri i\u00e7in u\u00e7tan uca klinik geli\u015ftirme hizmetleri sunan bilimsel odakl\u0131, tam hizmet S\u00f6zle\u015fmeli Ara\u015ft\u0131rma Organizasyonu (CRO) olarak faaliyet g\u00f6sterir. Entegre \"tek durak\" modeli, Faz I-IV deneylerini kapsar ve d\u00fczenleyici dan\u0131\u015fmanl\u0131ktan merkezi laboratuvar hizmetlerine kadar her \u015feyi i\u00e7erir.<\/p> <p>\u015eirket, genellikle b\u00fcy\u00fck rakipler taraf\u0131ndan g\u00f6z ard\u0131 edilen k\u00fc\u00e7\u00fck ve orta \u00f6l\u00e7ekli biyoteknoloji firmalar\u0131na stratejik olarak odaklan\u0131r. Bu odak, %95'in \u00fczerinde m\u00fc\u015fteri tutma oranlar\u0131yla son derece yap\u0131\u015fkan m\u00fc\u015fteri ili\u015fkileri yaratm\u0131\u015ft\u0131r. \u00d6zel ClinTrak sistemi, t\u0131bbi, d\u00fczenleyici, operasyon, laboratuvar ve g\u00f6r\u00fcnt\u00fcleme hizmetleri aras\u0131nda \u00e7apraz fonksiyonel ekipleri koordine eder.<\/p> <p><strong>2025 \u0130lgin\u00e7 Ger\u00e7ek<\/strong>: Medpace'in Bayrak Gemisi Site Program\u0131, sekt\u00f6r standartlar\u0131na k\u0131yasla %30 daha h\u0131zl\u0131 deney ba\u015flatma s\u00fcreleri sa\u011flar, hayat kurtaran tedavilerin pazara h\u0131zla ula\u015fmas\u0131na yard\u0131mc\u0131 olurken m\u00fc\u015fterileri i\u00e7in rekabet avantajlar\u0131 yarat\u0131r.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>Medpace&#8217;in Mevcut Piyasa Konumunu Anlamak<\/h2>\n<p><strong>25 A\u011fustos 2025 itibar\u0131yla Medpace Holdings (MEDP) hisseleri hisse ba\u015f\u0131na 463,64 $ seviyesinde i\u015flem g\u00f6r\u00fcyor<\/strong>\u2014t\u00fcm zamanlar\u0131n en y\u00fcksek seviyelerine yak\u0131n etkileyici bir konum. Hisse senedi, patlay\u0131c\u0131 2. \u00e7eyrek kazan\u00e7 sonu\u00e7lar\u0131n\u0131n ard\u0131ndan 22 Temmuz 2025&#8217;te 477,73 $ zirvesine ula\u015farak inan\u0131lmaz bir yolculuk yapt\u0131.<\/p>\n<p>Takviminize not edin: <strong>20 Ekim 2025<\/strong> bir sonraki kritik tarihiniz. Medpace&#8217;in 3. \u00e7eyrek kazan\u00e7 raporunu yay\u0131nlayaca\u011f\u0131 g\u00fcn bu. Tarihsel olarak, bu a\u00e7\u0131klamalar \u00f6nemli \u00f6l\u00e7\u00fcde hareket yaratm\u0131\u015ft\u0131r.<\/p>\n<h3>Kazan\u00e7 Raporlar\u0131 MEDP Hissesini Nas\u0131l Hareket Ettirir<\/h3>\n<p>Son tarihleri inceledi\u011fimizde g\u00fc\u00e7l\u00fc kazan\u00e7 sonras\u0131 performans\u0131n net bir \u00f6r\u00fcnt\u00fcs\u00fc g\u00f6r\u00fcl\u00fcyor:<\/p>\n<table>\n<thead>\n<tr>\n<th>Tarih<\/th>\n<th>Olay<\/th>\n<th>Haber \u00d6ncesi Fiyat<\/th>\n<th>Haber Sonras\u0131 De\u011fi\u015fim<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>21 Temmuz 2025<\/td>\n<td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>~400 $<\/td>\n<td><strong>%57 art\u0131\u015f<\/strong><\/td>\n<\/tr>\n<tr>\n<td>Nisan 2025<\/td>\n<td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>358 $<\/td>\n<td><strong>%9,3 gelir art\u0131\u015f\u0131<\/strong><\/td>\n<\/tr>\n<tr>\n<td>Ocak 2025<\/td>\n<td>\u00d6nceki Rehberlik<\/td>\n<td>325 $<\/td>\n<td><strong>\u0130stikrarl\u0131 y\u00fckseli\u015f<\/strong><\/td>\n<\/tr>\n<tr>\n<td>Ekim 2024<\/td>\n<td>3. \u00c7eyrek 2024<\/td>\n<td>298 $<\/td>\n<td><strong>Beklentileri a\u015ft\u0131<\/strong><\/td>\n<\/tr>\n<tr>\n<td>Temmuz 2024<\/td>\n<td>2. \u00c7eyrek 2024<\/td>\n<td>275 $<\/td>\n<td><strong>G\u00fc\u00e7l\u00fc sipari\u015f b\u00fcy\u00fcmesi<\/strong><\/td>\n<\/tr>\n<tr>\n<td>Nisan 2024<\/td>\n<td>1. \u00c7eyrek 2024<\/td>\n<td>250 $<\/td>\n<td><strong>Piyasa toparlanmas\u0131<\/strong><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>\u00d6r\u00fcnt\u00fc a\u00e7\u0131k: Medpace, yat\u0131r\u0131mc\u0131lar\u0131 heyecanland\u0131ran sonu\u00e7lar sunmaya devam ediyor. En dramatik hareket, 2. \u00e7eyrek 2025 sonras\u0131 ger\u00e7ekle\u015fti; hisse senedi %57 patlad\u0131, gelir %14,2 artarak 603,3 milyon $ oldu ve hisse ba\u015f\u0131 kazan\u00e7 tahminleri 0,12 $ a\u015ft\u0131.<\/p>\n<h3>6 Ayl\u0131k Fiyat Yolculu\u011fu Analizi<\/h3>\n<p>\u015eubat-A\u011fustos 2025 aras\u0131nda MEDP hisseleri etkileyici bir performans sergiledi:<\/p>\n<ul>\n<li><strong>\u015eubat 2025<\/strong>: Yakla\u015f\u0131k 340 $ seviyesinde i\u015flem g\u00f6rerek 4. \u00e7eyrek 2024 sonu\u00e7lar\u0131n\u0131n ard\u0131ndan momentum kazand\u0131<\/li>\n<li><strong>Mart 2025<\/strong>: Pozitif sekt\u00f6r havas\u0131 ve biyoteknoloji finansman iyile\u015fmeleriyle 380 $ seviyesine ula\u015ft\u0131<\/li>\n<li><strong>May\u0131s 2025<\/strong>: %9,3 gelir art\u0131\u015f\u0131 g\u00f6steren g\u00fc\u00e7l\u00fc 1. \u00e7eyrek kazan\u00e7lar\u0131n\u0131n ard\u0131ndan 400 $ s\u0131n\u0131r\u0131n\u0131 a\u015ft\u0131<\/li>\n<li><strong>Temmuz 2025<\/strong>: 2. \u00e7eyrek sonu\u00e7lar\u0131 beklentileri a\u015f\u0131nca 477 $ seviyesine f\u0131rlad\u0131<\/li>\n<li><strong>A\u011fustos 2025<\/strong>: Yakla\u015f\u0131k 463 $ civar\u0131nda konsolide olarak sa\u011fl\u0131kl\u0131 destek seviyeleri g\u00f6steriyor<\/li>\n<\/ul>\n<p>Bu, yakla\u015f\u0131k olarak <strong>%36 b\u00fcy\u00fcme<\/strong> anlam\u0131na geliyor ve biyoteknoloji sekt\u00f6r\u00fc ile genel piyasa endekslerinin \u00e7ok \u00fczerinde bir performans sergiliyor.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2>\n<p>Mevcut analist projeksiyonlar\u0131 ve \u015firket performans trendlerine dayanarak:<\/p>\n<ul>\n<li><strong>2025 Y\u0131l Sonu<\/strong>: 480-520 $ aral\u0131\u011f\u0131 (g\u00fc\u00e7l\u00fc tatil \u00e7eyre\u011fi performans\u0131 bekleniyor)<\/li>\n<li><strong>2026 Tahmini<\/strong>: 550-600 $ (piyasa geni\u015flemesi ve devam eden sipari\u015f d\u00f6n\u00fc\u015f\u00fcm\u00fc)<\/li>\n<li><strong>2028 Projeksiyonu<\/strong>: 700-800 $ (terap\u00f6tik alan hakimiyeti ve k\u00fcresel geni\u015fleme)<\/li>\n<li><strong>2030 Vizyonu<\/strong>: 900-1.100 $ (sekt\u00f6r liderli\u011fi ve potansiyel sat\u0131n almalar)<\/li>\n<\/ul>\n<p><strong>Karar<\/strong>: Uzun vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in G\u00dc\u00c7L\u00dc ALIM. \u015eirketin entegre CRO modeli, sa\u011flam m\u00fc\u015fteri ili\u015fkileri ve y\u00fcksek b\u00fcy\u00fcme potansiyeline sahip terap\u00f6tik alanlara maruziyeti, devam eden ba\u015far\u0131 i\u00e7in m\u00fckemmel bir konumda olmas\u0131n\u0131 sa\u011fl\u0131yor.<\/p>\n<h2>MEDP Yat\u0131r\u0131mc\u0131lar\u0131 i\u00e7in Risk Analizi<\/h2>\n<h3>Dikkate Al\u0131nmas\u0131 Gereken Potansiyel Riskler<\/h3>\n<ul>\n<li><strong>Biyoteknoloji Finansman Dalgalanmas\u0131<\/strong>: Medpace&#8217;in i\u015fi, biyoteknoloji \u015firketlerinin klinik deneyler i\u00e7in finansman sa\u011flamas\u0131na do\u011frudan ba\u011fl\u0131d\u0131r. Finansman s\u0131k\u0131la\u015ft\u0131\u011f\u0131nda (<a href=\"https:\/\/www.ainvest.com\/news\/medpace-50-stock-surge-unpacking-catalyst-clinical-outsourcing-giant-surge-2507\/\">2022&#8217;de g\u00f6r\u00fcld\u00fc\u011f\u00fc gibi<\/a>), iptal oranlar\u0131 dramatik \u015fekilde artabilir.<\/li>\n<li><strong>Y\u00fcksek De\u011ferleme Endi\u015feleri<\/strong>: 31,19 ileriye d\u00f6n\u00fck F\/K oran\u0131yla, baz\u0131 analistler hissenin k\u0131sa vadede tam de\u011ferine ula\u015fm\u0131\u015f olabilece\u011fini d\u00fc\u015f\u00fcn\u00fcyor. Ortalama analist fiyat hedefi 406 $ seviyesinde olup mevcut seviyelerden k\u0131sa vadeli d\u00fc\u015f\u00fc\u015f potansiyeli g\u00f6steriyor.<\/li>\n<li><strong>Rekabet Bask\u0131lar\u0131<\/strong>: CRO sekt\u00f6r\u00fc olduk\u00e7a rekabet\u00e7i olmaya devam ediyor, b\u00fcy\u00fck oyuncular s\u00fcrekli yenilik yap\u0131yor. Medpace&#8217;in %16,2 FAV\u00d6K marj\u0131, sekt\u00f6r ortalamas\u0131 olan %18-20&#8217;nin biraz gerisinde.<\/li>\n<li><strong>Reg\u00fclasyon Ba\u011f\u0131ml\u0131l\u0131\u011f\u0131<\/strong>: Medpace m\u00fc\u015fterilerine FDA\/EMA onay s\u00fcre\u00e7lerinde yard\u0131mc\u0131 olurken, herhangi b\u00fcy\u00fck bir d\u00fczenleyici de\u011fi\u015fiklik deney s\u00fcrelerini ve maliyetleri etkileyebilir.<\/li>\n<\/ul>\n<h3>2025 \u0130\u00e7in Olumlu \u0130\u015faretler<\/h3>\n<ul>\n<li><strong>Patlay\u0131c\u0131 B\u00fcy\u00fcme Momentum<\/strong>: 2. \u00e7eyrek 2025 sonu\u00e7lar\u0131 %14,2 gelir art\u0131\u015f\u0131 ve yeni i\u015f \u00f6d\u00fcllerinde %12,6 art\u0131\u015f g\u00f6sterdi ($620,5 milyon) (<a href=\"https:\/\/www.ainvest.com\/news\/medpace-holdings-45-stock-surge-deep-dive-q2-2025-earnings-future-clinical-outsourcing-2507\/\">AInvest<\/a>).<\/li>\n<li><strong>Devasa Sipari\u015f G\u00fcvencesi<\/strong>: 2,85 milyar $ sipari\u015f birikimi ve \u00f6n\u00fcm\u00fczdeki 12 ayda 1,75 milyar $ d\u00f6n\u00fc\u015f\u00fcm potansiyeli ile gelir g\u00f6r\u00fcn\u00fcrl\u00fc\u011f\u00fc son derece g\u00fc\u00e7l\u00fc.<\/li>\n<li><strong>Sekt\u00f6r R\u00fczgarlar\u0131<\/strong>: Klinik ara\u015ft\u0131rmalarda merkezi olmayan deneylere ve yapay zeka entegrasyonuna do\u011fru kay\u0131\u015f, Medpace&#8217;in g\u00fc\u00e7l\u00fc y\u00f6nleri ve hizmet teklifleriyle do\u011frudan \u00f6rt\u00fc\u015f\u00fcyor.<\/li>\n<li><strong>M\u00fc\u015fteri Tutma M\u00fckemmelli\u011fi<\/strong>: %95&#8217;in \u00fczerinde m\u00fc\u015fteri tutma oranlar\u0131, tam hizmet modelinin yap\u0131\u015fkanl\u0131\u011f\u0131n\u0131 ve hizmet kalitesini g\u00f6steriyor.<\/li>\n<\/ul>\n<h2>\u00d6nemli Haberlerin Etki Analizi<\/h2>\n<p>Medpace&#8217;in 2025 y\u0131l\u0131, tek b\u00fcy\u00fck bir hikaye ile \u015fekillendi: <strong>2. \u00c7eyrek Kazan\u00e7 Patlamas\u0131<\/strong>.<\/p>\n<p>21 Temmuz 2025&#8217;te \u015firket, piyasada \u015fok etkisi yaratan sonu\u00e7lar\u0131 a\u00e7\u0131klad\u0131:<\/p>\n<ul>\n<li>Gelir: 603,3 milyon $ (%14,2 Y\u0131ll\u0131k Art\u0131\u015f)<\/li>\n<li>Hisse Ba\u015f\u0131na Kazan\u00e7 (EPS): 3,10 $ (tahminleri 0,12 $ a\u015ft\u0131)<\/li>\n<li>Yeni i\u015f \u00f6d\u00fclleri: 620,5 milyon $ (%12,6 art\u0131\u015f)<\/li>\n<li>Sipari\u015f birikimi: 2,85 milyar $<\/li>\n<\/ul>\n<p>Hisse senedi, kazan\u00e7 s\u00fcrprizlerinin bu hisseyi ne kadar dramatik hareket ettirebilece\u011fini g\u00f6steren tarihi %57 art\u0131\u015fla yan\u0131t verdi. Bu izole bir olay de\u011fildi\u2014Medpace, analist takibine g\u00f6re EPS tahminlerini %100 oran\u0131nda a\u015fm\u0131\u015ft\u0131r.<\/p>\n<p>\u015eirket ayr\u0131ca 2025 tam y\u0131l rehberli\u011fini 2,42-2,52 milyar $ gelir ve 405-428 milyon $ GAAP net gelir olarak y\u00fckseltti, y\u00f6netimin devam eden uygulamaya olan g\u00fcvenini g\u00f6sterdi.<\/p>\n<h2>Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<p>T\u00fcm veri noktalar\u0131n\u0131 analiz ettikten sonra, i\u015fte uygulanabilir tavsiyem:<\/p>\n<ol>\n<li><strong>Ortalama Maliyetle Al\u0131m Yap\u0131n<\/strong>: Hissenin volatilitesi g\u00f6z \u00f6n\u00fcne al\u0131nd\u0131\u011f\u0131nda, pozisyonunuzu bir kerede tamamen almak yerine kademeli olarak olu\u015fturmay\u0131 d\u00fc\u015f\u00fcn\u00fcn<\/li>\n<li><strong>Kazan\u00e7 Uyar\u0131lar\u0131 Ayarlay\u0131n<\/strong>: Takviminize 20 Ekim&#8217;i i\u015faretleyin ve kazan\u00e7 sonras\u0131 f\u0131rsatlar i\u00e7in fiyat uyar\u0131lar\u0131 kurmay\u0131 d\u00fc\u015f\u00fcn\u00fcn<\/li>\n<li><strong>Uzun Vadeli D\u00fc\u015f\u00fcn\u00fcn<\/strong>: MEDP&#8217;nin i\u015f modeli, biyoteknoloji finansman d\u00f6ng\u00fclerini atlatabilecek sab\u0131rl\u0131 yat\u0131r\u0131mc\u0131lar\u0131 destekler<\/li>\n<li><strong>Esprili Ger\u00e7eklik Kontrol\u00fc<\/strong>: &#8220;MEDP ticareti yapmak, klinik deney sonu\u00e7lar\u0131n\u0131 izlemek gibidir\u2014bazen \u00e7\u0131\u011f\u0131r a\u00e7an tedavi stat\u00fcs\u00fc al\u0131rs\u0131n\u0131z, bazen plasebo etkisi. Anahtar, istatistiksel anlaml\u0131l\u0131\u011f\u0131 sa\u011flamak i\u00e7in yeterli deneme sitesi (\u00e7e\u015fitlendirme) sahibi olmakt\u0131r!&#8221;<\/li>\n<\/ol>\n<h2>Ad\u0131m Ad\u0131m: Medpace Holdings, Inc. (MEDP) Hisseleri Nas\u0131l Al\u0131n\u0131r<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Platformunuzu Se\u00e7in<\/td>\n<td>NASDAQ eri\u015fimi ve rekabet\u00e7i komisyon oranlar\u0131 sunan bir arac\u0131 kurum se\u00e7in<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesab\u0131n\u0131z\u0131 Fonlay\u0131n<\/td>\n<td>Fon transferi yap\u0131n\u2014bir\u00e7ok platform sadece 100 $ ile ba\u015flaman\u0131za izin verir<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>G\u00fcncel Fiyat\u0131 Ara\u015ft\u0131r\u0131n<\/td>\n<td>MEDP&#8217;nin 25 A\u011fustos 2025 itibar\u0131yla yakla\u015f\u0131k 463,64 $ olan g\u00fcncel fiyat\u0131n\u0131 kontrol edin<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Limit Emirleri Kullan\u0131n<\/td>\n<td>Volatil d\u00f6nemlerde planlad\u0131\u011f\u0131n\u0131zdan daha fazla \u00f6deme yapmamak i\u00e7in maksimum al\u0131\u015f fiyat\u0131n\u0131z\u0131 belirleyin<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Pozisyonu \u0130zleyin<\/td>\n<td>Yat\u0131r\u0131m\u0131n\u0131z\u0131 takip edin ve kazan\u00e7 tarihleri ile fiyat hedefleri i\u00e7in uyar\u0131lar kurmay\u0131 d\u00fc\u015f\u00fcn\u00fcn<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>MEDP Yat\u0131r\u0131mc\u0131lar\u0131 \u0130\u00e7in Pocket Option Neden Mant\u0131kl\u0131?<\/h2>\n<p>MEDP gibi hisselerde pozisyon olu\u015fturmak isteyenler i\u00e7in Pocket Option, modern yat\u0131r\u0131m ihtiya\u00e7lar\u0131yla m\u00fckemmel uyum sa\u011flayan birka\u00e7 avantaj sunar:<\/p>\n<ul>\n<li><strong>Minimum Para Yat\u0131rma Esnekli\u011fi<\/strong>: Sadece 5 $ ile ba\u015flayarak stratejileri test edebilir veya MEDP pozisyonunuzu \u00f6nemli sermaye taahh\u00fcd\u00fc olmadan olu\u015fturmaya ba\u015flayabilirsiniz<\/li>\n<li><strong>H\u0131zl\u0131 Hesap Do\u011frulama<\/strong>: Tek bir belge kullanarak 1 dakikal\u0131k KYC s\u00fcreci sayesinde, kay\u0131t olmadan ticarete dakikalar i\u00e7inde ba\u015flayabilirsiniz<\/li>\n<li><strong>\u00c7e\u015fitli Para \u00c7ekme Se\u00e7enekleri<\/strong>: 100&#8217;den fazla para \u00e7ekme y\u00f6ntemi, konumunuz veya tercihiniz ne olursa olsun k\u00e2rlar\u0131n\u0131za kolay eri\u015fim sa\u011flar<\/li>\n<\/ul>\n<p>Bu \u00f6zellikler, MEDP gibi volatil hisselerde pozisyonlar\u0131n\u0131 kademeli olarak olu\u015fturmak isteyen yat\u0131r\u0131mc\u0131lar i\u00e7in Pocket Option&#8217;u \u00f6zellikle cazip k\u0131lar ve yat\u0131r\u0131m yakla\u015f\u0131m\u0131 \u00fczerinde esneklik ve kontrol sa\u011flar.<\/p>\n<h2>Medpace Holdings: Klinik Ara\u015ft\u0131rma G\u00fcc\u00fc<\/h2>\n<p>Medpace, biyoteknoloji, ila\u00e7 ve medikal cihaz \u015firketleri i\u00e7in u\u00e7tan uca klinik geli\u015ftirme hizmetleri sunan bilimsel odakl\u0131, tam hizmet S\u00f6zle\u015fmeli Ara\u015ft\u0131rma Organizasyonu (CRO) olarak faaliyet g\u00f6sterir. Entegre &#8220;tek durak&#8221; modeli, Faz I-IV deneylerini kapsar ve d\u00fczenleyici dan\u0131\u015fmanl\u0131ktan merkezi laboratuvar hizmetlerine kadar her \u015feyi i\u00e7erir.<\/p>\n<p>\u015eirket, genellikle b\u00fcy\u00fck rakipler taraf\u0131ndan g\u00f6z ard\u0131 edilen k\u00fc\u00e7\u00fck ve orta \u00f6l\u00e7ekli biyoteknoloji firmalar\u0131na stratejik olarak odaklan\u0131r. Bu odak, %95&#8217;in \u00fczerinde m\u00fc\u015fteri tutma oranlar\u0131yla son derece yap\u0131\u015fkan m\u00fc\u015fteri ili\u015fkileri yaratm\u0131\u015ft\u0131r. \u00d6zel ClinTrak sistemi, t\u0131bbi, d\u00fczenleyici, operasyon, laboratuvar ve g\u00f6r\u00fcnt\u00fcleme hizmetleri aras\u0131nda \u00e7apraz fonksiyonel ekipleri koordine eder.<\/p>\n<p><strong>2025 \u0130lgin\u00e7 Ger\u00e7ek<\/strong>: Medpace&#8217;in Bayrak Gemisi Site Program\u0131, sekt\u00f6r standartlar\u0131na k\u0131yasla %30 daha h\u0131zl\u0131 deney ba\u015flatma s\u00fcreleri sa\u011flar, hayat kurtaran tedavilerin pazara h\u0131zla ula\u015fmas\u0131na yard\u0131mc\u0131 olurken m\u00fc\u015fterileri i\u00e7in rekabet avantajlar\u0131 yarat\u0131r.<\/p>\n"},"faq":[{"question":"Medpace Holdings, Inc. (MEDP) hisseleri nereden al\u0131nabilir?","answer":"MEDP hisseleri NASDAQ borsas\u0131nda i\u015flem g\u00f6rmektedir. G\u00fcvenilir bir arac\u0131 kurum veya online yat\u0131r\u0131m platformu \u00fczerinden sat\u0131n alabilirsiniz."},{"question":"MEDP hisseleri i\u00e7in minimum yat\u0131r\u0131m tutar\u0131 nedir?","answer":"Minimum yat\u0131r\u0131m tutar\u0131 se\u00e7ti\u011finiz platforma ba\u011fl\u0131d\u0131r. Baz\u0131 platformlar 100 $ gibi d\u00fc\u015f\u00fck tutarlarla yat\u0131r\u0131m yapman\u0131za olanak tan\u0131r."},{"question":"Medpace'in b\u00fcy\u00fcme potansiyeli nedir?","answer":"Medpace, klinik ara\u015ft\u0131rma alan\u0131nda g\u00fc\u00e7l\u00fc b\u00fcy\u00fcme potansiyeline sahip olup, 2025-2030 aras\u0131nda hisse fiyat\u0131n\u0131n \u00f6nemli \u00f6l\u00e7\u00fcde artmas\u0131 beklenmektedir."},{"question":"MEDP hisseleri hangi riskleri ta\u015f\u0131r?","answer":"Biyoteknoloji finansman dalgalanmalar\u0131, y\u00fcksek de\u011ferleme, rekabet bask\u0131lar\u0131 ve d\u00fczenleyici de\u011fi\u015fiklikler MEDP hisseleri i\u00e7in ba\u015fl\u0131ca risklerdir."},{"question":"Yeni ba\u015flayan biri MEDP hissesi al\u0131rken nelere dikkat etmeli?","answer":"Yeni ba\u015flayanlar, kademeli al\u0131m yapmal\u0131, kazan\u00e7 tarihlerini takip etmeli ve uzun vadeli yat\u0131r\u0131m perspektifi benimsemelidir."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Medpace Holdings, Inc. (MEDP) hisseleri nereden al\u0131nabilir?","answer":"MEDP hisseleri NASDAQ borsas\u0131nda i\u015flem g\u00f6rmektedir. G\u00fcvenilir bir arac\u0131 kurum veya online yat\u0131r\u0131m platformu \u00fczerinden sat\u0131n alabilirsiniz."},{"question":"MEDP hisseleri i\u00e7in minimum yat\u0131r\u0131m tutar\u0131 nedir?","answer":"Minimum yat\u0131r\u0131m tutar\u0131 se\u00e7ti\u011finiz platforma ba\u011fl\u0131d\u0131r. Baz\u0131 platformlar 100 $ gibi d\u00fc\u015f\u00fck tutarlarla yat\u0131r\u0131m yapman\u0131za olanak tan\u0131r."},{"question":"Medpace'in b\u00fcy\u00fcme potansiyeli nedir?","answer":"Medpace, klinik ara\u015ft\u0131rma alan\u0131nda g\u00fc\u00e7l\u00fc b\u00fcy\u00fcme potansiyeline sahip olup, 2025-2030 aras\u0131nda hisse fiyat\u0131n\u0131n \u00f6nemli \u00f6l\u00e7\u00fcde artmas\u0131 beklenmektedir."},{"question":"MEDP hisseleri hangi riskleri ta\u015f\u0131r?","answer":"Biyoteknoloji finansman dalgalanmalar\u0131, y\u00fcksek de\u011ferleme, rekabet bask\u0131lar\u0131 ve d\u00fczenleyici de\u011fi\u015fiklikler MEDP hisseleri i\u00e7in ba\u015fl\u0131ca risklerdir."},{"question":"Yeni ba\u015flayan biri MEDP hissesi al\u0131rken nelere dikkat etmeli?","answer":"Yeni ba\u015flayanlar, kademeli al\u0131m yapmal\u0131, kazan\u00e7 tarihlerini takip etmeli ve uzun vadeli yat\u0131r\u0131m perspektifi benimsemelidir."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Medpace Holdings, Inc. (MEDP) Hisseleri Nas\u0131l Al\u0131n\u0131r - Medpace Holdings, Inc. (MEDP) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-medpace-holdings\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Medpace Holdings, Inc. (MEDP) Hisseleri Nas\u0131l Al\u0131n\u0131r - Medpace Holdings, Inc. (MEDP) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-medpace-holdings\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-25T16:52:11+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-medpace-holdings\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-medpace-holdings\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"Medpace Holdings, Inc. (MEDP) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Medpace Holdings, Inc. (MEDP) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-25T16:52:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-medpace-holdings\/\"},\"wordCount\":21,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-medpace-holdings\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-medpace-holdings\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-medpace-holdings\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-medpace-holdings\/\",\"name\":\"Medpace Holdings, Inc. (MEDP) Hisseleri Nas\u0131l Al\u0131n\u0131r - Medpace Holdings, Inc. (MEDP) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-medpace-holdings\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-medpace-holdings\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp\",\"datePublished\":\"2025-08-25T16:52:11+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-medpace-holdings\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-medpace-holdings\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-medpace-holdings\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp\",\"width\":1408,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-medpace-holdings\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Medpace Holdings, Inc. (MEDP) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Medpace Holdings, Inc. (MEDP) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Medpace Holdings, Inc. (MEDP) Hisseleri Nas\u0131l Al\u0131n\u0131r - Medpace Holdings, Inc. (MEDP) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-medpace-holdings\/","og_locale":"tr_TR","og_type":"article","og_title":"Medpace Holdings, Inc. (MEDP) Hisseleri Nas\u0131l Al\u0131n\u0131r - Medpace Holdings, Inc. (MEDP) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-medpace-holdings\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-25T16:52:11+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-medpace-holdings\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-medpace-holdings\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"Medpace Holdings, Inc. (MEDP) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Medpace Holdings, Inc. (MEDP) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-25T16:52:11+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-medpace-holdings\/"},"wordCount":21,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-medpace-holdings\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-medpace-holdings\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-medpace-holdings\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-medpace-holdings\/","name":"Medpace Holdings, Inc. (MEDP) Hisseleri Nas\u0131l Al\u0131n\u0131r - Medpace Holdings, Inc. (MEDP) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-medpace-holdings\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-medpace-holdings\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp","datePublished":"2025-08-25T16:52:11+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-medpace-holdings\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-medpace-holdings\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-medpace-holdings\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp","width":1408,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-medpace-holdings\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Medpace Holdings, Inc. (MEDP) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Medpace Holdings, Inc. (MEDP) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":349287,"slug":"how-to-buy-medpace-holdings","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Medpace Holdings, Inc. (MEDP) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Medpace Holdings, Inc. (MEDP)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-medpace-holdings\/"},"pt_AA":{"locale":"pt_AA","id":349284,"slug":"how-to-buy-medpace-holdings","post_title":"Como comprar a\u00e7\u00f5es da Medpace Holdings, Inc. (MEDP) - Investimento em a\u00e7\u00f5es da Medpace Holdings, Inc. (MEDP)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-medpace-holdings\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/349290","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=349290"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/349290\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334036"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=349290"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=349290"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=349290"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}